StockData
McKesson Corp logo

McKesson Corp (MCK) stock

MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3027% above fair value
$1084.43−7.24 (-0.66%)

Close on Nov 18, 2026Market cap $126.43BP/E 29.0Yield 0.29%

McKesson operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

McKesson's operating income for the twelve months ending Jun 30, 2026 was $6.50B, up 46.6% year over year. For fiscal 2026 it was $6.21B, up 40.5% from the year before. Over ten years it grew 5.8% a year on average. The highest annual figure on record is $7.12B in fiscal 2017.

Annual operating income

PeriodPeriod endValueChange
FY2026Mar 31, 2026$6.21B+40.5%
FY2025Mar 31, 2025$4.42B+13.1%
FY2024Mar 31, 2024$3.91B-10.8%
FY2023Mar 31, 2023$4.38B+115.0%
FY2022Mar 31, 2022$2.04B–
FY2021Mar 31, 2021-$5.04B-302.5%
FY2020Mar 31, 2020$2.49B+180.9%
FY2019Mar 31, 2019$886.00M+16.3%
FY2018Mar 31, 2018$762.00M-89.3%
FY2017Mar 31, 2017$7.12B+100.9%
FY2016Mar 31, 2016$3.55B+19.4%
FY2015Mar 31, 2015$2.97B+21.7%
FY2014Mar 31, 2014$2.44B+3.9%
FY2013Mar 31, 2013$2.35B+10.5%
FY2012Mar 31, 2012$2.12B+16.6%
FY2011Mar 31, 2011$1.82B-9.3%
FY2010Mar 31, 2010$2.01B+67.9%
FY2009Mar 31, 2009$1.20B-19.1%
FY2008Mar 31, 2008$1.48B–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$1.32B+27.3%
Q4 FY2026CQ1 2026Mar 31, 2026$2.15B+35.1%
Q3 FY2026CQ4 2025Dec 31, 2025$1.62B+32.3%
Q2 FY2026CQ3 2025Sep 30, 2025$1.41B+143.4%
Q1 FY2026CQ2 2025Jun 30, 2025$1.04B+0.7%
Q4 FY2025CQ1 2025Mar 31, 2025$1.59B+30.8%
Q3 FY2025CQ4 2024Dec 31, 2024$1.22B+90.7%
Q2 FY2025CQ3 2024Sep 30, 2024$578.00M-39.2%
Q1 FY2025CQ2 2024Jun 30, 2024$1.03B-6.5%
Q4 FY2024CQ1 2024Mar 31, 2024$1.22B+24.1%
Q3 FY2024CQ4 2023Dec 31, 2023$642.00M-48.3%
Q2 FY2024CQ3 2023Sep 30, 2023$951.00M-15.4%
Q1 FY2024CQ2 2023Jun 30, 2023$1.10B+6.2%
Q4 FY2023CQ1 2023Mar 31, 2023$980.00M+54.8%
Q3 FY2023CQ4 2022Dec 31, 2022$1.24B+316.4%
Q2 FY2023CQ3 2022Sep 30, 2022$1.12B+108.5%
Q1 FY2023CQ2 2022Jun 30, 2022$1.04B+82.4%
Q4 FY2022CQ1 2022Mar 31, 2022$633.00M-37.3%
Q3 FY2022CQ4 2021Dec 31, 2021$298.00M–
Q2 FY2022CQ3 2021Sep 30, 2021$539.00M-15.0%
Q1 FY2022CQ2 2021Jun 30, 2021$568.00M-16.2%
Q4 FY2021CQ1 2021Mar 31, 2021$1.01B+16.2%
Q3 FY2021CQ4 2020Dec 31, 2020-$7.36B-2145.0%
Q2 FY2021CQ3 2020Sep 30, 2020$634.00M+1.3%
Q1 FY2021CQ2 2020Jun 30, 2020$678.00M+6.9%
Q4 FY2020CQ1 2020Mar 31, 2020$869.00M–
Q3 FY2020CQ4 2019Dec 31, 2019$360.00M-47.3%
Q2 FY2020CQ3 2019Sep 30, 2019$626.00M-9.1%
Q1 FY2020CQ2 2019Jun 30, 2019$634.00M+663.9%
Q4 FY2019CQ1 2019Mar 31, 2019-$569.00M–
Q3 FY2019CQ4 2018Dec 31, 2018$683.00M-18.1%
Q2 FY2019CQ3 2018Sep 30, 2018$689.00M+188.3%
Q1 FY2019CQ2 2018Jun 30, 2018$83.00M-86.9%
Q4 FY2018CQ1 2018Mar 31, 2018-$944.00M-119.9%
Q3 FY2018CQ4 2017Dec 31, 2017$834.00M+0.4%
Q2 FY2018CQ3 2017Sep 30, 2017$239.00M-58.8%
Q1 FY2018CQ2 2017Jun 30, 2017$633.00M–
Q4 FY2017CQ1 2017Mar 31, 2017$4.74B–
Q3 FY2017CQ4 2016Dec 31, 2016$831.00M–
Q2 FY2017CQ3 2016Sep 30, 2016$580.00M–

More McKesson figures

See a number that looks wrong?